Prokidney (PROK) Shares Outstanding (2021 - 2026)

Prokidney (PROK) has 6 years of Shares Outstanding data on file, last reported at $142.0 million in Q1 2026.

• Shares Outstanding for Q1 2026 came in at $142.0 million, down 12.98% year-over-year; the trailing twelve-month figure through Mar 2026 was $142.0 million (down 12.98% YoY), and the FY2025 annual result was $159.3 million, up 24.37% from the prior year.
• Shares Outstanding retreated to $142.0 million in Q1 2026 per PROK's latest filing, from $159.3 million in the prior quarter.
• Over five years, Shares Outstanding peaked at $186.5 million in Q1 2022 and troughed at $61.5 million in Q3 2022.
• A 5-year average of $138.5 million and a median of $161.6 million in 2025 frame the typical range for Shares Outstanding.
• The sharpest annual moves came in 2022 and 2024: Shares Outstanding jumped 2848.62% in 2022, then dropped 23.91% in 2024.
• A 5-year view of Shares Outstanding shows it stood at $171.6 million in 2022, then dropped by 1.91% to $168.3 million in 2023, then declined by 23.91% to $128.1 million in 2024, then advanced by 24.37% to $159.3 million in 2025, then slipped by 10.85% to $142.0 million in 2026.
• Business Quant data shows PROK's Shares Outstanding at $142.0 million in Q1 2026, $159.3 million in Q4 2025, and $159.3 million in Q3 2025.